Munich Startup
rnhale

rnhale

RNhale develops inhaled RNA therapeutics for COPD and severe asthma. Our platform transforms RNA-loaded lipid nanoparticles into an inhalable dry powder, enabling direct, local delivery to the lungs. By addressing the key challeng...

Gründung2023
Business ModelSonstiges
BrancheLife Science

Über rnhale

RNhale develops inhaled RNA therapeutics for COPD and severe asthma. Our platform transforms RNA-loaded lipid nanoparticles into an inhalable dry powder, enabling direct, local delivery to the lungs. By addressing the key challenges of pulmonary RNA delivery, stability, deep lung deposition, and cellular uptake, our technology unlocks a more effective path for RNA-based therapies to reach their target. Our goal is to develop effective, locally-acting respiratory therapies that address disease at its molecular source. Our vision: to redefine the treatment of severe lung diseases.

Unsere Mission

We are bringing a new generation of efficient treatments to patients with COPD and asthma.

Unsere Vision

Redefining the therapy of severe lung diseases.

Mehr davon

Entdecke weitere Artikel, Startups und Events aus dem Ökosystem

Rnhale: Inhalierbare RNA für neue Therapien
Interviews

Rnhale: Inhalierbare RNA für neue Therapien

23.03.26
4 Min.
20.000 Ladepunkte: Fryte kooperiert mit Smatrics
Deals

20.000 Ladepunkte: Fryte kooperiert mit Smatrics

28.08.26
3 Min.
Zura Health: Mehr als nur ein weiterer Fitness-Tracker
Interviews

Zura Health: Mehr als nur ein weiterer Fitness-Tracker

28.08.26
8 Min.